Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $5.84 $8.40 Friday, 10th May 2024 VERV stock ended at $6.01. This is 5.50% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.35% from a day low at $5.88 to a day high of $6.43.
90 days $5.84 $19.34
52 weeks $5.84 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
Jan 26, 2022 $31.61 $32.46 $29.30 $29.65 945 600
Jan 25, 2022 $31.38 $32.23 $29.78 $30.80 915 000
Jan 24, 2022 $31.98 $32.71 $29.28 $31.83 1 170 600
Jan 21, 2022 $32.37 $35.17 $32.37 $32.52 1 032 700
Jan 20, 2022 $34.00 $35.41 $33.00 $33.18 527 700
Jan 19, 2022 $30.99 $35.24 $30.94 $33.51 856 000
Jan 18, 2022 $32.53 $33.20 $30.64 $30.73 776 000
Jan 14, 2022 $30.62 $33.12 $30.13 $32.79 709 500
Jan 13, 2022 $31.99 $32.59 $29.91 $30.91 549 500
Jan 12, 2022 $33.69 $33.77 $31.70 $31.79 406 300
Jan 11, 2022 $32.17 $33.56 $31.43 $33.47 330 000
Jan 10, 2022 $31.70 $32.44 $30.04 $32.34 372 800
Jan 07, 2022 $31.07 $33.19 $31.05 $32.05 293 500
Jan 06, 2022 $32.11 $32.61 $29.98 $31.70 486 500
Jan 05, 2022 $36.41 $37.08 $31.94 $32.19 653 655
Jan 04, 2022 $39.90 $39.90 $35.77 $35.99 411 715
Jan 03, 2022 $37.32 $39.45 $35.26 $39.36 503 625
Dec 31, 2021 $36.96 $39.00 $36.01 $36.87 288 142
Dec 30, 2021 $36.02 $38.97 $35.98 $37.72 394 951
Dec 29, 2021 $35.98 $35.99 $34.34 $35.94 398 622
Dec 28, 2021 $39.24 $39.90 $35.01 $35.97 391 982
Dec 27, 2021 $41.61 $42.63 $39.47 $40.01 365 397
Dec 23, 2021 $39.30 $41.44 $38.52 $41.32 523 459
Dec 22, 2021 $39.98 $39.98 $36.74 $39.10 735 836
Dec 21, 2021 $39.47 $42.76 $39.01 $40.43 531 186
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT